| Sarah Sivinski, PA-C | |
|
6325 Emerald Pkwy, Dublin, OH 43016-3241 | |
| (614) 876-6673 | |
| Not Available |
| Full Name | Sarah Sivinski |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 6325 Emerald Pkwy, Dublin, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922556653 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 50.005655RX (Ohio) | Secondary |
| 363A00000X | Physician Assistant | 9109958 (Florida) | Secondary |
| 363A00000X | Physician Assistant | 50.005655RX (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Sivinski, PA-C 6325 Emerald Pkwy Ste 1b, Dublin, OH 43016-3241 Ph: () - | Sarah Sivinski, PA-C 6325 Emerald Pkwy, Dublin, OH 43016-3241 Ph: (614) 876-6673 |
News Archive
Back and neck pain sufferers who divide the most frequently prescribed muscle relaxant may be getting anywhere from half to one-and-a-half times the amount of medicine they believe they are taking, suggests a new study examining the practice of tablet splitting.
A new commentary published online in the Annals of the American Thoracic Society provides an exhaustive examination of published research that discusses whether air pollution may be linked to worse COVID-19 outcomes.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
A diverse group of health care and consumer organizations released five policy recommendations this week that are designed to promote better medication adherence and improved health outcomes for patients.
Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to research presented today at the 2017 Multidisciplinary Thoracic Cancers Symposium.
› Verified 8 days ago